Evidence map›Paper›PMID 32705355›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2020

NMR metabolomic analysis of bacterial resistance pathways using multivalent quaternary ammonium functionalized macromolecules.

Michelle L Aries, Mary J Cloninger

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Advances in Microbial NMR Metabolomics.Advances in experimental medicine and biology · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michelle L AriesDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT, 59717, USA.
Mary J CloningerDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT, 59717, USA. mcloninger@montana.edu.ORCID 0000-0002-7551-1003

Funding

Using Dendrimers to Design Multivalent Therapeutic AgentsR01GM062444 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI CLONINGER, MARY J · 2001 to 2015
$3.5M
NIGMS NIH HHS R01 GM062444
6 · The paper itself

Abstract

introductionMultivalent antimicrobial dendrimers are an exciting new system that is being developed to address the growing problem of drug resistant bacteria. Nuclear Magnetic Resonance (NMR) metabolomics is a quantitative and reproducible method for the determination of bacterial response to environmental stressors and for visualization of perturbations to biochemical pathways.

objectivesNMR metabolomics is used to elucidate metabolite differences between wild type and antimicrobially mutated Escherichia coli (E. coli) samples.

methodsProton (

resultsThe wild type and mutated E. coli samples were separated into distinct sample sets by hierarchical clustering, principal component analysis (PCA) and sparse partial least squares discriminate analysis (sPLS-DA). Metabolite components of membrane fortification and energy related pathways had a significant p value and fold change between the wild type and mutated E. coli. Amino acids commonly associated with membrane fortification from cationic antimicrobials, such as lysine, were found to have a higher concentration in the mutated E. coli than in the wild type E. coli. N-acetylglucosamine, a major component of peptidoglycan synthesis, was found to have a 25-fold higher concentration in the mid log phase of the mutated E. coli than in the mid log phase of the wild type.

conclusionThe metabolic profile suggests that E. coli change their peptidoglycan composition in order to garner protection from the highly positively charged and multivalent C

Indexed as

Amino AcidsAmmonium CompoundsBacteriaDrug Resistance, BacterialEscherichia coliMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMetabolomeMetabolomicsAmino AcidsAmmonium CompoundsAntibiotic resistanceDABCODendrimersMetabolomicsNuclear magnetic resonanceQuaternary ammonium compounds

Identifiers

PMID32705355
PMCPMC9389846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.